Improving the Diagnosis of Traveller's Fevers in Point Of Care (POC)

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02868411

Enrollment

159

Registered

2016-08-16

Start date

2013-06-11

Completion date

2022-10-26

Last updated

2023-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traveller's Fever

Brief summary

A point-of-care laboratory (POC) was set at North Hospital, Marseille, France for the diagnosis in less than two hours of traveller's fever caused by known pathogens, close to the reception of Emergency service. In this instance 30% of patients have no etiological diagnosis after the POC traveller's fever tests . The objective of this study is to implement a new diagnosis strategy relying on the hypothesis that a rectal swab would improve the etiological diagnosis of traveller's fever of at least 10%.

Interventions

OTHERRectal Swab

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Patient admitted for traveller's fever requiring a microbiological examination with a Traveller's fever POC kit * Patient who freely signed the informed consent form * Patient affiliated to a social security regime

Exclusion criteria

* Pregnant or breastfeeding women * Adult patient under guardianship * Patient deprived with liberty under court order * Patient refusing or unable to sign the informed consent form

Design outcomes

Primary

Measure	Time frame
Percentage of patients admitted for traveller's fever with a confirmed etiological diagnosis	1 day

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026